Warfarin and a Self-Prescribed Blood-Quickening Formula
Mr. L, a 68-year-old retired teacher with atrial fibrillation, has taken warfarin 5 mg daily for four years; his INR has been stable at 2.3–2.6. Six weeks ago he began a self-purchased 'Blood Quickening' herbal capsule for chronic shoulder pain. The label lists Dan Shen (Salvia miltiorrhiza) 500 mg, Hong Hua (Carthamus tinctorius) 300 mg, and Tao Ren (Prunus persica) 300 mg per capsule; he takes two capsules twice daily. He presents to your clinic with gum bleeding when brushing, two new bruises on his forearm, and an INR of 4.8 drawn yesterday. He denies black stools, hematuria, or headache. He asks whether he should simply skip his warfarin dose tonight and continue the herbs because 'they are natural.'
1. Identify the likely pharmacokinetic and pharmacodynamic mechanisms behind this patient's elevated INR and outline your immediate clinical actions, including what you must not do.
Read the worked answer
Mechanisms. Dan Shen contains tanshinones and salvianolic acids that inhibit platelet aggregation and may inhibit CYP2C9-mediated warfarin metabolism and displace warfarin from albumin. Hong Hua and Tao Ren add antiplatelet and anticoagulant activity. The combination produces a pharmacodynamic and possible pharmacokinetic interaction, raising INR and bleeding risk.
Immediate actions. Stop the herbal product immediately. Do not tell the patient to skip, reduce, or stop warfarin himself. Contact his anticoagulation clinic or prescribing physician the same day; an INR of 4.8 with active gum bleeding and bruising requires urgent clinical review. Advise him to avoid aspirin, NSAIDs, and alcohol, and to seek emergency care for melena, hematuria, severe headache, or uncontrolled bleeding. Vitamin K or dose adjustment is the prescriber's decision, not yours.
What not to do. Do not adjust warfarin, do not give vitamin K independently, and do not restart the herbs until the prescriber has reviewed the case. Document the product label, doses, INR, bleeding signs, advice given, and all communications.
2. How would you structure counseling, informed consent, and documentation for this adverse event, and what external reporting is appropriate?
Read the worked answer
Counseling should be nonjudgmental and concrete: explain that 'natural' does not mean interaction-free, identify the specific herbs and mechanisms, and give written instructions to stop the product and seek same-day medical review. Obtain informed consent for any future herbal care by reviewing all prescription drugs, supplements, and doses; explain that INR monitoring may be needed before and after any new herb.
Documentation should include a focused SOAP note: subjective report of bleeding and supplement use; objective INR, bruises, gum bleeding; assessment of probable herb-warfarin interaction; plan including discontinuation, referral, and follow-up. Record the label, lot number if available, and the patient's questions.
Report the suspected adverse reaction to the national pharmacovigilance program and, if required locally, to the manufacturer. Keep records according to jurisdictional retention rules. Do not alter the medical record after the fact; use a dated addendum if new information arrives.
3. If the shoulder pain still requires treatment after medical stabilization, propose a safer management strategy and justify it.
Read the worked answer
After the INR is controlled and the prescriber agrees, avoid systemic herbs with antiplatelet or anticoagulant activity, including Dan Shen, Hong Hua, Tao Ren, and other blood-moving herbs. Prefer acupuncture, physical therapy, topical agents with low systemic absorption, and exercise. If topical menthol or capsaicin is used, check skin integrity and avoid excessive application.
If oral herbal treatment is unavoidable, choose herbs with minimal platelet or CYP2C9 effects, start low, and coordinate INR checks with the anticoagulation clinic. Avoid combining with NSAIDs. Reassess bleeding risk at each visit and document the shared decision. The key judgment is that symptom relief must not come at the cost of uncontrolled anticoagulation.